ITMCTR2100004678
Recruiting
Phase 4
A randomized double-blind controlled clinical study on the effects of qishen yiqi dropping pills on exercise endurance and quality of life in patients with coronary heart disease after interventional therapy
China-Japan Friendship Hospital0 sitesTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- China-Japan Friendship Hospital
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Have a clear understanding of the research content and purpose, participate in the study voluntarily, and sign the informed consent form by himself / herself;
- •2\. It is consistent with the diagnostic criteria of Western medicine for stable coronary heart disease;
- •3\. Patients with Qi deficiency and blood stasis syndrome who meet the above diagnostic criteria of TCM;
- •4\. Complete the overall treatment plan after PCI;
- •5\. Within 1 week to 6 months after PCI;
- •6\. The age is between 18 and 75 years old.
Exclusion Criteria
- •1\. There are contraindications of cardiopulmonary exercise test;
- •2\. Plan for coronary artery bypass grafting or heart transplantation;
- •3\. Within 3 months before admission: stroke, transient ischemic attack; carotid artery or other major vascular surgery; persistent ventricular tachycardia or ventricular fibrillation;
- •4\. Ventricular arrhythmia was not controlled effectively (antiarrhythmic drugs or implantable defibrillator were ineffective;
- •5\. Uncorrected primary obstruction or severe reflux valvular disease, non dilated (restrictive) or hypertrophic cardiomyopathy;
- •6\. Patients with second or third degree heart block or sick sinus syndrome, without permanent pacemaker, who need implantable devices for heart failure;
- •7\. Obstructive or bronchospasmodic lung disease (such as asthma, bronchitis, etc.) requires oral or inhaled bronchodilator or hormone therapy;
- •8\. Pregnant or lactating women and women who plan to become pregnant during the trial period;
- •9\. Cancer or other systemic diseases, the expected survival time is less than 12 months;
- •10\. Use other clinical trial drugs or participate in medical device test within 30 days before enrollment;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
A randomized double-blind controlled clinical study of Qiangxin compound in the treatment of type 2 cardiorenal syndrome under the hierarchical management mode of Integrated Chinese and Western MedicineITMCTR2000003812Traditional Chinese Medicine Hospital of Shanghai
Completed
Not Applicable
evaluation of the ability of a drug (Tranexamic acid) in reducing blood loss during and after surgery in head and neck cancer patientsCTRI/2018/05/014184AIIMS86
Not yet recruiting
Phase 2
A Clinical trial to study the effect of SDLSNT21 tablet in Patients of Nidranash(Insomnia).Health Condition 1: G470- InsomniaCTRI/2023/02/049355Dean Faculty of Ayurved
Recruiting
Not Applicable
The Comparison between two method of minisurgical percutaneous dilated tracheostomyThe relationship between two methods of small throat surgery through the skin.IRCT20150107020592N8Masih Daneshvari Hospital66
Recruiting
Phase 1
Randomized double-blind control clinical study of lower-risk myelodysplastic syndrom (kideny Yang Deficiency) of compound Shenlu granuleITMCTR2000004040Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine